This endocrine disorder, analogous in many respects to human metabolic syndrome, is defined by a constellation of clinical and metabolic abnormalities, including regional adiposity, increased risk of endocrinopathic laminitis, and insulin dysregulation manifesting as hyperinsulinemia or an exaggerated insulin response [2,3]. This evidence concerns the gene INS and Hyperinsulinemia.